The purpose of this study is to investigate the effects of intravenous lidocaine infusion on pancreatic cancer. This study focuses on patients undergoing robotic pancreatectomy, a surgical procedure for pancreatic cancer.
This study evaluates how lidocaine affects certain cellular activities and pathways in cancer cells found in the blood. It looks at how lidocaine might change the number and behavior of these cells during surgery.
- Who can participate: Adults with resectable pancreatic cancer confirmed through tests can participate. They must have at least one measurable tumor and have signed the consent form.
- Study details: Participants will be divided into two groups: one receiving a saline infusion and the other receiving a lidocaine infusion. A placebo is a substance that looks like the investigational medicine but does not contain any medicine.
How understandable was the trial content above?
Hard to understand
Easy to understand